Search

Your search keyword '"Dell’Isola, Serena"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Dell’Isola, Serena" Remove constraint Author: "Dell’Isola, Serena" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
27 results on '"Dell’Isola, Serena"'

Search Results

1. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

5. Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network

6. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

8. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel

9. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

10. The evolutionary scenario of hepatocellular carcinoma in Italy: an update

11. THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2

13. The role of teicoplanin in the treatment of SARS‐CoV‐2 infection: A retrospective study in critically ill COVID‐19 patients (Tei‐COVID study)

14. Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel

16. High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients

19. Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case‐control study.

20. Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma

21. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

22. Daclatasvir, Sofosbuvir With or Without Ribavirin for 24 Weeks In Hepatitis C Genotype 3 Cirrhosis: A Real-Life Study

25. Years of life that could be saved from prevention of hepatocellular carcinoma

26. Superinfections in patients treated with Teicoplanin as anti‐SARS‐CoV‐2 agent.

Catalog

Books, media, physical & digital resources